Lockheed Martin shares nudged up 0.7% during a trading session that saw volume plummet 77% below average, making more of a ...

Wedbush just dialed down Airbnb’s price target from $175 to $150, citing a foggy economic outlook clouded by tariffs, ...

F M Investments boosted its stake in Regeneron Pharmaceuticals by 8.5% in Q4, grabbing 7,003 shares worth nearly $5 million.

Investment firm Baird cut its price target for Cigna from $388 to $362 but kept its Outperform rating intact. The move ...

DRW Securities shaved off 64.3% of its Deere & Company stake in Q4, dumping 1,983 shares and hanging on to just 1,103. Several other firms followed suit, either trimming or barely dipping their toes ...

Representative Jefferson Shreve recently dipped into Vertex Pharmaceuticals stock, buying between $15,001 and $50,000 worth on March 13th. He revealed this transaction in a disclosure dated April 11th ...

Bristol Myers Squibb has teamed up with Optellum to sharpen its lung cancer game using artificial intelligence, proving even Big Pharma knows it’s smarter to bring robots to a knife fight. This ...